Lung Disease News and Research

RSS

Could oropharyngeal microflora predict COVID-19 patients' need for respiratory support?

Researchers identify oropharyngeal bacteria and metabolic pathways that are predictive of the need for respiratory support in COVID-19 patients.

7 Mar 2022

The relative dynamics of infection with the Delta and Omicron SARS-CoV-2 variants in aged and young Syrian hamsters

Researchers demonstrated the relative pathogenicity of SARS-CoV-2 Omicron and Delta variants of concern in Syrian hamsters.

7 Mar 2022

How does COVID-19 affect patients with idiopathic pulmonary fibrosis?

A new study discusses the outcomes of idiopathic pulmonary fibrosis patients with confirmed SARS-CoV-2 infection.

6 Mar 2022

Gas chromatography-ion mobility spectrometry helps diagnose COVID-19 and predict disease severity

Researchers assess the ability of GC-IMS to differentiate between COVID-19 and other respiratory infections, as well as predict disease severity.

4 Mar 2022

Long-acting monoclonal antibody shows potential to offer RSV protection for all infants

Nirsevimab showed 74.5 percent efficacy against medically attended lower respiratory tract infections caused by respiratory syncytial virus (RSV) in healthy infants, according to an international, randomized, placebo-controlled Phase 3 clinical trial.

3 Mar 2022

SARS-CoV-2 occurrence compared with other respiratory viruses in children with acute respiratory infections

The current study examined the incidence of COVID-19 in children with ARI relative to other respiratory viruses during the second and third waves.

22 Feb 2022

Mouse-adapted virus model to study persistent COVID induced lung disease

Researchers develop a mouse model to identify early biomarkers and test countermeasures needed to detect and prevent PASC.

21 Feb 2022

Children with severe COVID-19 show low mucosal neutralizing activity against SARS-CoV-2

A new study examines neutralizing responses to the ancestral variant of SARS-CoV-2, as well as against later variants of concern.

16 Feb 2022

Incomplete repair of the damaged lung may contribute to death from COVID-19 and non-COVID ARDS

Investigators studying lung cells have discovered that the normal repair process that occurs after lung disease or injury appears to be incomplete but still ongoing in patients who died of COVID-19 and non-COVID acute respiratory distress syndrome (ARDS).

15 Feb 2022

Omicron resists antibodies, causes less severe disease than previous SARS-CoV-2variants

In two recent studies, researchers at Washington University School of Medicine in St. Louis found evidence that the omicron variant of the virus that causes COVID-19 causes less severe disease than previous variants — at least in rodents — but that many antibody-based therapies may not be effective against it.

10 Feb 2022

Study examines whether viagra-like drug may be effective in treating vascular dementia

A new study, published today in Alzheimer's & Dementia, tested whether tadalafil, a drug closely related to Viagra, may be effective in treating people with vascular dementia.

9 Feb 2022

Reviewing breath biomarkers for inflammatory respiratory diseases

The prevalence of inflammatory airway diseases such as lung cancer, chronic obstructive pulmonary disease (COPD) and asthma is on the rise internationally, placing strain on health systems around the world. Lung cancer is the leading cause of death of all cancers.

From Owlstone Medical Ltd 8 Feb 2022

Study explores SARS-CoV-2 manifestations and related hospitalizations in infants

A new study examined the clinical manifestations of SARS-CoV-2 infections, disease severity, and related hospitalization in infants in Canada.

8 Feb 2022

Investigating the immunology of COVID-19 infected children

Researchers published a new study that focused on the key principles of developmental immunology associated with immunobiology and the clinical impacts of COVID-19 infections in children and adults.

7 Feb 2022

Study shows positive outcomes in COVID-19 patients who underwent lung transplants

For many COVID-19 patients with irrecoverable lung damage, transplantation is the only option for survival. However, there is limited information about the long-term outcomes of these patients, including postoperative complications, hospital length of stay and survival.

3 Feb 2022

Lung Disease News and Research

Could oropharyngeal microflora predict COVID-19 patients' need for respiratory support?

The relative dynamics of infection with the Delta and Omicron SARS-CoV-2 variants in aged and young Syrian hamsters

How does COVID-19 affect patients with idiopathic pulmonary fibrosis?

Gas chromatography-ion mobility spectrometry helps diagnose COVID-19 and predict disease severity

Long-acting monoclonal antibody shows potential to offer RSV protection for all infants

SARS-CoV-2 occurrence compared with other respiratory viruses in children with acute respiratory infections

Mouse-adapted virus model to study persistent COVID induced lung disease

Children with severe COVID-19 show low mucosal neutralizing activity against SARS-CoV-2

Incomplete repair of the damaged lung may contribute to death from COVID-19 and non-COVID ARDS

Omicron resists antibodies, causes less severe disease than previous SARS-CoV-2variants

Study examines whether viagra-like drug may be effective in treating vascular dementia

Reviewing breath biomarkers for inflammatory respiratory diseases

Study explores SARS-CoV-2 manifestations and related hospitalizations in infants

Investigating the immunology of COVID-19 infected children

Study shows positive outcomes in COVID-19 patients who underwent lung transplants

Multimorbidity at middle-age linked to higher risk of dementia later in life

Scientists discover new insights about lymphangioleiomyomatosis

Phico Therapeutics establishes Scientific Advisory Board

Researchers identify genetic cause of rare interstitial lung disease in a young child

Effects of multi-nutrient supplementation on COVID-19 severity in elderly patients

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News